NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/07/2026
Voltar para busca
Dado oficial do USPTO
ONCOJET PLASMA SOLUTION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
09/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 44
Data de depósito
21/10/2016
Data de registro
30/10/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/05/2025
Última transação
09/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
DE
Examinador
LEIPZIG, MARC J
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the dark red wording "ONCOJET" above the grey wording "PLASMA SOLUTION".
Titulares e representantes
Titulares
Leibniz-Institut für Plasmaforschung und Technologie e.V.
Representantes
Nicholas D Wells Legends Law Group, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary and therapeutic preparations and substancespharmaceutical preparations for the treatment of cancer and cancer-related conditionsveterinary preparations for the treatment of cancer and cancer-related conditions in mammals; sanitary preparations for medical purpose; plasters for medical purposes; medical dressings; teeth filing material and dental impression materials; disinfectants; all aforementioned products particularly for use in oncology
Classe 10
Instruments and devices for plasma medicalveterinary and therapeutic purposesatmospheric pressure plasma jets and dielectric barrier discharges in the nature of electric therapy apparatus for direct treatment in the nature of treating tumors and tumor cellsmedical plasma devices in the nature of ultrasonic therapy apparatus and liquid dispensers for medical use for generating and applying one or more liquid-based active agents for use in medical tumor therapy; pumps for medicalveterinary and therapeutics usedispenser pumps for medical purposes for mixing gaseous or liquid agents and for generating low pressure regimes for easier plasma ignition; devices and apparatus for administering or applying medicines and substances for medicalveterinary and therapeutic useneedle-based and needle-free injection systems consisting primarily of needle-free syringes and jet injectors for applying one or more liquid-based active agentsplasma generated reactive gases or direct atmospheric pressure plasma; devices and apparatus for plasma medical useplasma sources being plasma jets or dielectric barrier discharges for use in the treatment of cancer; and replacement parts and fittings for the aforementioned products; all aforementioned products particularly for use in oncology
Classe 44
Medical services; veterinary services; and medical therapeutic services in the field of oncology; healthcare and beauty care for humans and animals; all aforementioned services particularly tailored for the field of oncology
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
16/01/2026
C71T
CANCELLED SECTION 71
16/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/04/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
06/02/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
05/02/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
30/10/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28/09/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/09/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/08/2018
PUBO
PUBLISHED FOR OPPOSITION
14/08/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/07/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/06/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/06/2018
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
05/06/2018
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
05/06/2018
CNCF
ACTION CONTINUING A FINAL - COMPLETED
05/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/05/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/11/2017
GNFR
FINAL REFUSAL E-MAILED
11/11/2017
CNFR
FINAL REFUSAL WRITTEN
11/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/10/2017
ATRV
ATTORNEY REVIEW COMPLETED
25/08/2017
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
25/08/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
17/08/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/04/2017
RFRR
REFUSAL PROCESSED BY MPU
20/04/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/04/2017
CNRT
NON-FINAL ACTION WRITTEN
17/04/2017
MAFR
APPLICATION FILING RECEIPT MAILED
15/04/2017
DOCK
ASSIGNED TO EXAMINER
11/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/04/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCOJET PLASMA SOLUTION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.